DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



MRI Homepage

Hawaii takes aim at kidney disease with 7T preclinical MR system Will track changes in kidneys to determine disease origins

MR research raises the question: Is it time to ditch the necktie? Compressing the jugular vein and carotid artery reduces cerebral blood flow

The importance of breast MR screening for high-risk patients Experts weigh in on MR's emerging role in breast cancer diagnostics

All-optical ultrasound could pave way for combined MR-ultrasound imaging Three orders of magnitude faster than current optical systems

India hospital where man died in MR accident seeks new machine Adding a second scanner in addition to fixing the first raises concerns

MR okay for cardiac device patients – if done right Consulting with electrophysiologists is essential

Guerbet and IBM Watson to develop AI-based liver diagnostics solution Supports liver diagnostics in CT and MR

Canon showcases new 3T MR research system at meeting in France Generates images comparable to those acquired with 7T

Praxair in deal to sell European assets to Taiyo Nippon Sanso Move is dependent on the successful closing of the Praxair-Linde merger

MITA calls for timely exemption process for Section 301 tariffs Calls for exemption of medical imaging technology

Children's National Health System is
the first U.S. pediatric institution to
perform MR-HIFU to treat osteoid osteoma

Children’s National Health System first U.S. pediatric institution to use MR-HIFU

by John R. Fischer , Staff Reporter
Doctors at Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System have identified a new technique that uses MR and ultrasound technology to remove bone tumors in children.

Children’s National is the first children’s hospital in the U.S. to perform magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) as a noninvasive alternative for treating osteoid osteoma, compared to the standard practice of radiofrequency ablation and surgery. The findings of its physicians were published in The Journal of Pediatrics.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

“MR-guided HIFU is different from other techniques in that it is completely noninvasive. There is no requirement for any sort of incision … in radiofrequency ablation, a bone drill is used to find the osteoid osteoma under CT guidance,” said Dr. Karun Sharma, director of Interventional Radiology at Children's National and principal investigator for the osteoid osteoma trial. “MR-HIFU is done with MR guidance, and there’s no ionizing radiation exposure with MR.”

The use of MR-HIFU is part of the Image-Guided Noninvasive Therapeutic Energy (IGNITE) program, a collaboration between Sheikh Zayed Institute and the departments of Radiology, Oncology, Surgery, and Anesthesiology at Children's National that aims to develop technology for minimally invasive and noninvasive surgery and combination therapy approaches that improve quality of life and outcome for pediatric patients.

MR-HIFU uses focused sound wave energy to heat up and destroy tumors under the guidance of MR. This reduces risks of infection and bone fracture. It is also faster, compared to CT-guided RFA and other methods, with an estimated completion time of 90 minutes or less.

A clinical trial examined and compared nine patients who underwent MR-HIFU to nine who underwent CT-guided RFA. All patients were between the ages of 6 and 16. Those who underwent MR-HIFU were between 6 and 16 and those who underwent CT-guided RFA were between 6 and 10. The results found that MR-HIFU is a more feasible and safe method, eliminating risks of incision and ionizing radiation compared to the use of RFA.

“It is noninvasive, so there is much less collateral damage than surgery, for instance, where you’re not disrupting surrounding, normal tissue,” said Sharma. “It’s precise in that way. The other thing is we’re more sensitive about exposing children to ionizing radiation.”

MR-HIFU is authorized to treat uterine fibroids, prostate cancer, essential tremor and bone metastases of several types of cancers in adults. There is hope that the technology will one day expand into treatment for brain conditions, such as epilepsy and seizures.

Sharma says that such technology has the potential to become “commonplace”, and perhaps a standard tool one day for adults and children.

“I think there is a lot of potential for this technology in pediatrics … we’re still early in the game, and we have to do the clinical trials, but for certain applications, it holds a lot of promise,” he said.

Children's National is currently studying the technique in two other pediatric clinical trials, for desmoid tumors and sarcoma.

MRI Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.